Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Califf Maintains Desire To Stay At US FDA, But Will Either Presidential Candidate Keep Him?

Executive Summary

FDA Commissioner says every day at the agency is fun, but the decision to remain will be made by the next president.

You may also be interested in...

Finally … Rachel Sherman Takes Califf's Old FDA Job

After months of speculation, FDA veteran Rachel Sherman becomes deputy commissioner for medical products and tobacco.

Califf Says He Doesn't Need To Fight To Stay

FDA's new commissioner may be asked to leave agency when new president arrives, but he says it might not come to that.

Withdraw Califf FDA Nomination, Sanders Demands

Citing close ties to the biopharmaceutical industry and a lack of commitment to lowering drug prices, Sen. Bernie Sanders (I-VT) on Jan. 26 demanded President Barack Obama withdraw his nomination of Robert Califf to lead the FDA.

Related Content


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts